Research

The Gastric Precancerous Conditions Study

Gastric cancer afflicts 27,000 Americans annually and carries a dismal prognosis. One reason for poor outcomes is late diagnosis, as the majority of gastric cancers in the United States are identified at a relatively advanced stage, when curative resection is unlikely. Gastric intestinal metaplasia (GIM) is a precancerous change in the stomach that increases the risk of subsequent gastric cancer multiple-fold.

The Gastric Precancerous Conditions Study (GAPS) is an observational study with two overarching objectives:

  1. To improve the non-invasive identification of patients with GIM, and
  2. To develop biological markers that predict which cases of GIM will progress to gastric cancer.
The Gastric Precancerous Conditions Study (GAPS)

Co-Principal Investigators: Dr. Robert Huang and Dr. Joo Ha Hwang

Learn more and join the study